Individual research projects

DC1: Design and discovery of novel GrnzB ligands and evaluation as diagnostics tools in CAR T cell therapy assessment​

DC2: Novel probes for imaging of tumor-associated proteases via Positron Emission Tomography (PET) and fluorescence microscopy​

DC3: Innovative Target Modulators (TMs) for simultaneous delivery of CAR T cell therapy, radio- and chemotherapy to tumors​

DC4: Innovative Target Modulators for FAP-targeting UniCAR T therapy

DC5: Design and discovery of novel cathepsin S ligands and their evaluation as PET and fluorescent probes for oncology diagnosis​

DC6: Characterization of the p38 MAPK pathway in the expression of TME proteases

​DC7: In vivo investigation of FAP-targeting UniCAR T cell therapies combined with radio- and chemotherapy

DC8: Novel probes for imaging of tumor-associated cathepsins via Positron Emission Tomography (PET) and fluorescence microscopy​

DC9: Microfluidics-based multilevel characterization and validation of innovative FAP-targeting immunotherapies​

DC10: Innovative in vitro and in vivo models for TME protease research​